Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

HEDSA discusses better services for students with disabilities
2010-09-30

At the gala dinner were, from the left: Anlia Pretorius, Chairperson of HEDSA and Head of the Disability Unit at the University of the Witwatersrand; Dr Blade Nzimande, Minister of Higher Education and Training; Ms Hetsie Veitch, Head of the Unit for Students with Disabilities at the UFS; and Prof. Niel Viljoen, Vice-Rector: Operations at the UFS.
Photo: Leonie Bolleurs

The first ever General Meeting of the Higher Education Disability Services Association (HEDSA) was held on the Main Campus of the University of the Free State (UFS) in Bloemfontein this week. HEDSA is a newly constituted body that represents the Disability Units from the various universities across the country.

The UFS is a member of HEDSA, which aims to work together to promote equal opportunities for students with disabilities in terms of access, participation and success in Higher Education.

The General Meeting forms part of the launching symposium with the theme: New Beginnings and New Directions. The symposium, attended by 15 higher education institutions in South Africa, served as a platform to explore innovative approaches to assist in improving services for students with disabilities.

Dr Blade Nzimande, Minister of Higher Education and Training, was one of the speakers at the gala dinner of this prestigious event. He said that there is still a lot of work to do to overcome discrimination against students as well as staff members with disabilities at higher education institutions. Minister Nzimande quoted from the Soudien report, a government-commissioned report that brought to light discrimination – especially racism and sexism – still endemic at South African universities. “Victims, in this instance referring to students and staff with disabilities, are denied the opportunity – either through a lack of access to opportunities or due to outright discrimination – to realise their full potential. In the process, the country is robbed of valuable but untapped human resources. Higher education institutions cause incalculable damage to South African society by failing to deal boldly with these issues. Where institutions have indeed taken action, the benefits to individuals, to the different social groups in the country, as well as to the institutions themselves, have been major.”

He stated that he believed that HEDSA as well as the symposium could play a vital role that would assist in this process.

Ms Hetsie Veitch, Head of the Unit for Students with Disabilities at the UFS, was elected as treasurer of this body for the following two years. Johnny Mokoka will represent the UFS in HEDSA’s National Student Organisation for Students with Disabilities that was established during the symposium this week.

Media Release
Issued by: Leonie Bolleurs
Strategic Communication
Tel: 051 401 2707
Sel: 0836455853
Email: bolleursl@ufs.ac.za  
30 September 2010

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept